» Articles » PMID: 21815811

The Top Five "game Changers" in Vaccinology: Toward Rational and Directed Vaccine Development

Overview
Journal OMICS
Date 2011 Aug 6
PMID 21815811
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the tremendous success of the classical "isolate, inactivate, and inject" approach to vaccine development, new breakthroughs in vaccine research are increasingly reliant on novel approaches that incorporate cutting edge technology and advances in innate and adaptive immunology, microbiology, virology, pathogen biology, genetics, bioinformatics, and many other disciplines in order to: (1) deepen our understanding of the key biological processes that lead to protective immunity, (2) observe vaccine responses on a global, systems level, and (3) directly apply the new knowledge gained to the development of next-generation vaccines with improved safety profiles, enhanced efficacy, and even targeted utility in select populations. Here we highlight five key components foundational to vaccinomics efforts: applied immunogenomics, next generation sequencing and other cutting-edge "omics" technologies, advanced bioinformatics and analysis techniques, and finally, systems biology applied to immune profiling and vaccine responses. We believe these "game changers" will play a critical role in moving us toward the rational and directed development of new vaccines in the 21st century.

Citing Articles

Protocol for a scoping review of potential vaccine candidates predicted by VaxiJen for different viral pathogens between 2017-2021.

Salod Z, Mahomed O Syst Rev. 2022; 11(1):284.

PMID: 36585703 PMC: 9801145. DOI: 10.1186/s13643-022-02121-0.


Recent developments in systems biology and genetic engineering toward design of vaccines for TB.

Singh Y, Beamer G, Sun X, Shukla P Crit Rev Biotechnol. 2021; 42(4):532-547.

PMID: 34641752 PMC: 11208086. DOI: 10.1080/07388551.2021.1951649.


Structural and immunological characterization of an epitope within the PAN motif of ectodomain I in apical membrane antigen 1 for vaccine development.

Rittipornlertrak A, Nambooppha B, Muenthaisong A, Punyapornwithaya V, Tiwananthagorn S, Chung Y PeerJ. 2021; 9:e11765.

PMID: 34316404 PMC: 8288113. DOI: 10.7717/peerj.11765.


In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus.

Signorazzi A, Pennings J, Etna M, Noya M, Coccia E, Huckriede A Vaccines (Basel). 2021; 9(6).

PMID: 34204532 PMC: 8234070. DOI: 10.3390/vaccines9060664.


Current Challenges in Vaccinology.

Kennedy R, Ovsyannikova I, Palese P, Poland G Front Immunol. 2020; 11:1181.

PMID: 32670279 PMC: 7329983. DOI: 10.3389/fimmu.2020.01181.


References
1.
Germain R . Vaccines and the future of human immunology. Immunity. 2010; 33(4):441-50. DOI: 10.1016/j.immuni.2010.09.014. View

2.
Cho J, Gelinas R, Wang K, Etheridge A, Piper M, Batte K . Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes. BMC Med Genomics. 2011; 4:8. PMC: 3035594. DOI: 10.1186/1755-8794-4-8. View

3.
Davies D, Wyatt L, Newman F, Earl P, Chun S, Hernandez J . Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J Virol. 2007; 82(2):652-63. PMC: 2224576. DOI: 10.1128/JVI.01706-07. View

4.
Lynn D, Winsor G, Chan C, Richard N, Laird M, Barsky A . InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol Syst Biol. 2008; 4:218. PMC: 2564732. DOI: 10.1038/msb.2008.55. View

5.
Alkhalil A, Hammamieh R, Hardick J, Ait Ichou M, Jett M, Ibrahim S . Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions. Virol J. 2010; 7:173. PMC: 2920256. DOI: 10.1186/1743-422X-7-173. View